Medifast, Inc. provided earnings guidance for the fourth quarter and full year of 2026. For the quarter, the company expects fourth quarter 2026 revenue to be in the range of $55 million to ...
Medifast, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales was USD 72.05 million compared to USD 89.41 ...
Results from the Phase 3 VISIONARY trial showed a 97.1% reduction in the risk of a composite kidney outcome event of kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results